Zelestra signs a power purchase agreement with Energize for 161.4 MWdc in Spain
Type: Ppa · Technology: Solar · Country: Spain · Capacity: 161.4 MW · Announced: 2024-09-25
Zelestra signed a 10-year power purchase agreement (PPA) with the Energize programme to supply around 161.4 MWdc of solar capacity in Spain, delivering approximately 305 GWh of renewable electricity annually to a cohort of pharmaceutical companies and suppliers.
Counterparties
- UCB Pharma SA (Offtaker)
- Perrigo Pharma International D.A.C (Offtaker)
- Takeda Pharmaceuticals International AG (Offtaker)
- Teva Pharmaceutical Industries Ltd (Offtaker)
- Zelestra (Seller)
- Energize (programme representing 24 pharmaceutical companies, including Takeda Pharmaceuticals International AG, Teva Pharmaceutical Industries Ltd., and UCB Pharma SA) (Offtaker)
- West Pharmaceutical Services, Inc (Offtaker)
- Avantor, Inc (Offtaker)
- Organon LLC (Offtaker)
📈 The Sherpa Signal — one notable infrastructure deal a day.